{"filing":{"accession_number":"0001193125-26-341434","cik":"0001287865","ticker":"MPT","company_name":"MEDICAL PROPERTIES TRUST INC","form":"8-K","filing_date":"2026-08-10","report_date":"2026-08-10","primary_document":"d115341d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1287865/000119312526341434/d115341d8k.htm"},"events":[{"id":26454,"run_id":24045,"accession_number":"0001193125-26-341434","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Medical Properties Trust issued a press release on August 10, 2026 announcing financial results for the three and six months ended June 30, 2026, including net loss of ($0.01) per share and NFFO of $0.15 per share for Q2 2026, with consolidated balance sheets, income statements, and FFO reconciliations.","company_name":"MEDICAL PROPERTIES TRUST INC","ticker":"MPT","filing_date":"2026-08-10","form":"8-K","submitted_at":null,"items":[{"id":27587,"accession_number":"0001193125-26-341434","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a clear earnings release for Q2 2026 (three and six months ended June 30, 2026). The press release announces financial and operating results including net loss of ($0.01) per share, NFFO of $0.15 per share, and consolidated financial statements with balance sheet and income statement data. Item 2.02 explicitly states the company \"issued a press release announcing its financial results\" with the exhibit attached, which is the standard disclosure mechanism for quarterly earnings.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T13:26:41.921687+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":26455,"run_id":24045,"accession_number":"0001193125-26-341434","anchor_item_number":"7.01","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"MPT Operating Partnership and MPT Finance Corporation entered into an exchange and purchase agreement to issue $2.4 billion in aggregate principal amount of new 9.25% senior secured notes due 2032, with proceeds to repay existing 2026 notes and approximately 50% of 2027 notes.","company_name":"MEDICAL PROPERTIES TRUST INC","ticker":"MPT","filing_date":"2026-08-10","form":"8-K","submitted_at":null,"items":[{"id":27588,"accession_number":"0001193125-26-341434","item_number":"7.01","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses entry into an exchange and purchase agreement for issuance of $2.4 billion in aggregate principal amount of new 9.25% senior secured notes due 2032, with proceeds to repay existing debt including 2026 notes and approximately 50% of 2027 notes. This is a material creation of new direct financial obligations under Item 2.03 (Debt Creation), though disclosed under Item 7.01 (Regulation FD Disclosure). The transaction significantly extends debt maturities and is expected to close imminently.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T13:26:41.921687+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":27587,"accession_number":"0001193125-26-341434","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a clear earnings release for Q2 2026 (three and six months ended June 30, 2026). The press release announces financial and operating results including net loss of ($0.01) per share, NFFO of $0.15 per share, and consolidated financial statements with balance sheet and income statement data. Item 2.02 explicitly states the company \"issued a press release announcing its financial results\" with the exhibit attached, which is the standard disclosure mechanism for quarterly earnings.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T13:26:41.921687+00:00","company_name":"MEDICAL PROPERTIES TRUST INC","ticker":"MPT","filing_date":"2026-08-10"},{"id":27588,"accession_number":"0001193125-26-341434","item_number":"7.01","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses entry into an exchange and purchase agreement for issuance of $2.4 billion in aggregate principal amount of new 9.25% senior secured notes due 2032, with proceeds to repay existing debt including 2026 notes and approximately 50% of 2027 notes. This is a material creation of new direct financial obligations under Item 2.03 (Debt Creation), though disclosed under Item 7.01 (Regulation FD Disclosure). The transaction significantly extends debt maturities and is expected to close imminently.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T13:26:41.921687+00:00","company_name":"MEDICAL PROPERTIES TRUST INC","ticker":"MPT","filing_date":"2026-08-10"}]}